Takeover

KIDSORTHOPEDIATRICS CORP

Surgical & Medical Instruments & Apparatus

Revenue
$236MFY2021: $98MFY2022: $122MFY2023: $149MFY2024: $205MFY2025: $236M
15% YoY
Operating margin
-16.6%FY2021: -18.4%FY2022: -20.8%FY2023: -18.0%FY2024: -17.1%FY2025: -16.6%
2.9% YoY
EBITDA
−$18MFY2021: −$7MFY2022: −$12MFY2023: −$9MFY2024: −$16MFY2025: −$18M
14% YoY
Market cap
$775M
Employees
602
$393K revenue each
Net debt / EBITDA
—
−$16M net debt
AI in 10-K
0.4
mentions per 10K words

Takeover score 5 of 13

Fixable underperformance 2 of 7

Buyer economics 2 of 4

Catalysts 1 of 2

Financials

MetricFY2021FY2022FY2023FY2024FY2025YoYTrend
Revenue$98M$122M$149M$205M$236M 15% FY2021: $98MFY2022: $122MFY2023: $149MFY2024: $205MFY2025: $236M
Operating income−$18M−$25M−$27M−$35M−$39M 12% FY2021: −$18MFY2022: −$25MFY2023: −$27MFY2024: −$35MFY2025: −$39M
Net income−$16M$1M−$21M−$38M−$40M 4.8% FY2021: −$16MFY2022: $1MFY2023: −$21MFY2024: −$38MFY2025: −$40M
Operating cash flow−$13M−$22M−$27M−$27M−$5M 82% FY2021: −$13MFY2022: −$22MFY2023: −$27MFY2024: −$27MFY2025: −$5M
Capex$8M$10M$17M$14M$11M 22% FY2021: $8MFY2022: $10MFY2023: $17MFY2024: $14MFY2025: $11M
Stock-based comp$6M$7M$11M$14M$18M 31% FY2021: $6MFY2022: $7MFY2023: $11MFY2024: $14MFY2025: $18M

Deal filings

None.

13D filers

FiledFilerFormStakeIntent
Sep 11, 2026Squadron Capital LLCSCHEDULE 13D/A47.6%Passive
Sep 1, 2026Squadron Capital LLCSCHEDULE 13D/A25.1%Passive
Sep 22, 2022Squadron Capital LLCSC 13D/A97.4%Passive
Aug 17, 2022Squadron Capital LLCSC 13D/A30.1%Passive
Mar 18, 2021Squadron Capital LLCSC 13D27.4%Active

Insider trading

Open-market buys, 12 mo
$0 · 0
Open-market sells, 12 mo
$48M · 26
Net
−$48M

Pay vs performance

YearCEO total compComp actually paidTSR (indexed)Peer TSR
FY2025——3075000
FY2024——5675000
FY2023——7972000
FY2022——9675000
FY2021——145100000